Exome sequencing identifies FLNC and ADD3 variants in a family with cardiomyopathy

Aim: Idiopathic cardiomyopathy is often genetic in origin, typically autosomal dominant, and restrictive cardiomyopathy (RCM) is the rarest form. Clinically, RCM prognosis is poor with most patients requiring heart transplant due to impaired diastolic function leading to heart failure. In some cases, desminopathy is also observed, whereby desmin protein aggregates in the myocardium. Many genes are known to be involved in cardiomyopathy, and we sought to find the pathogenic mutation of a four-generation family with RCM and desminopathy. Methods: We employed whole exome sequence analysis of four RCM patients from the family, to identify the underlying pathogenic mutation(s). Results: Analysis of the exome data led to identification of two putative pathogenic variants. One, a nonsense mutation in ADD3, encoding adducin 3, was found in the proband and his affected daughter, but not other family members. The other was a missense mutation (G1546S) in the gene encoding filamin C (FLNC), found in all of the affected individuals. Both of these proteins interact with proteins involved in sarcomere function, and are expressed in both heart and skeletal muscle. FLNC has recently been implicated as a cardiomyopathy gene, but ADD3 has not at this point. Conclusion: We present bioinformatic analyses that suggest that the FLNC variant is the major pathogenic variant affecting this family, but cannot rule out some contribution of the ADD3 mutation in at least two patients.

[1]  Robert W. Mills,et al.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy , 2017, Circulation. Cardiovascular genetics.

[2]  V. Álvarez,et al.  Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients , 2017, Circulation. Cardiovascular genetics.

[3]  H. Hakonarson,et al.  Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy , 2017, PloS one.

[4]  K. Claeys,et al.  Widening the spectrum of filamin-C myopathy: Predominantly proximal myopathy due to the p.A193T mutation in the actin-binding domain of FLNC , 2017, Neuromuscular Disorders.

[5]  M. Bang Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z‐Line Proteins , 2017, Journal of cellular physiology.

[6]  Michael A. Burke,et al.  Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[7]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[8]  R. Płoski,et al.  Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy , 2016, American journal of medical genetics. Part A.

[9]  J. Jais,et al.  Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC. , 2016, Revue neurologique.

[10]  D. Frishman,et al.  Genetic Spectrum of Idiopathic Restrictive Cardiomyopathy Uncovered by Next-Generation Sequencing , 2016, PloS one.

[11]  J. Bae,et al.  Data of methylome and transcriptome derived from human dilated cardiomyopathy , 2016, Data in brief.

[12]  E. González-López,et al.  Idiopathic Restrictive Cardiomyopathy Is Primarily a Genetic Disease. , 2016, Journal of the American College of Cardiology.

[13]  R. Bryson-Richardson,et al.  Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage. , 2016, Human molecular genetics.

[14]  T. Shaikh,et al.  Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy , 2016, Cold Spring Harbor molecular case studies.

[15]  R. Bryson-Richardson,et al.  FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency. , 2016, Human molecular genetics.

[16]  J. Schwartzentruber,et al.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human mutation.

[17]  R. Knöll,et al.  Desmin, desminopathy and the complexity of genetics. , 2016, Journal of molecular and cellular cardiology.

[18]  Laurie D. Smith,et al.  Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders. , 2016, Cold Spring Harbor perspectives in medicine.

[19]  W. Tang,et al.  Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies , 2015, Current Heart Failure Reports.

[20]  R. Franklin,et al.  Nomenclature and systems of classification for cardiomyopathy in children* , 2015, Cardiology in the Young.

[21]  Shuyang Zhang,et al.  Novel Phenotype–Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing , 2015, Journal of the American Heart Association.

[22]  Y. Pinto,et al.  Genetic advances in sarcomeric cardiomyopathies: state of the art , 2015, Cardiovascular research.

[23]  X. Puente,et al.  Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.

[24]  J. Ylänne,et al.  Small-Angle X-Ray Scattering Reveals Compact Domain-Domain Interactions in the N-Terminal Region of Filamin C , 2014, PloS one.

[25]  Karen S. Frese,et al.  Atlas of the clinical genetics of human dilated cardiomyopathy. , 2014, European heart journal.

[26]  W. Rottbauer,et al.  Aciculin interacts with filamin C and Xin and is essential for myofibril assembly, remodeling and maintenance , 2014, Journal of Cell Science.

[27]  D. Judge,et al.  Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction , 2014, Clinical Medicine Insights. Cardiology.

[28]  M. Tegenthoff,et al.  Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. , 2013, Journal of proteomics.

[29]  Heidi L Rehm,et al.  Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. , 2013, The Journal of molecular diagnostics : JMD.

[30]  J. Stone Updates to the WHO Classification of Cardiomyopathies , 2011 .

[31]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[32]  E. Arbustini,et al.  Restrictive cardiomyopathy , 2009, Current opinion in cardiology.

[33]  M. Wallace,et al.  Genetic linkage of a novel autosomal dominant restrictive cardiomyopathy locus , 2005, Journal of Medical Genetics.

[34]  G. Virdi,et al.  Clinical and molecular studies of a large family with desmin‐associated restrictive cardiomyopathy , 2001, Clinical genetics.

[35]  M. Gautel,et al.  Characterization of muscle filamin isoforms suggests a possible role of gamma-filamin/ABP-L in sarcomeric Z-disc formation. , 2000, Cell motility and the cytoskeleton.

[36]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[37]  J. Towbin Inherited cardiomyopathies. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[38]  A. Moss,et al.  Contemporary Definitions and Classification of the Cardiomyopathies , 2006 .